AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 129 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $28,000 | -61.6% | 470 | -81.9% | 0.00% | – |
| Q3 2019 | $73,000 | -65.7% | 2,600 | -53.9% | 0.00% | -100.0% |
| Q2 2019 | $213,000 | +752.0% | 5,642 | +374.9% | 0.00% | – |
| Q4 2018 | $25,000 | -71.6% | 1,188 | -47.1% | 0.00% | – |
| Q3 2018 | $88,000 | +282.6% | 2,247 | +184.1% | 0.00% | -100.0% |
| Q1 2018 | $23,000 | – | 791 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,806,832 | $50,862,321,000 | 38.71% |
| Casdin Capital, LLC | 400,000 | $11,204,000 | 3.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,525,410 | $42,727,000 | 1.92% |
| Opaleye Management Inc. | 180,000 | $5,041,000 | 1.78% |
| Redmile Group, LLC | 1,289,332 | $36,114,000 | 1.78% |
| Cormorant Asset Management, LP | 323,545 | $9,062,000 | 1.60% |
| Orbimed Advisors | 4,129,638 | $115,671,000 | 1.10% |
| Perceptive Advisors | 1,562,618 | $43,770,000 | 0.84% |
| Rock Springs Capital Management LP | 525,000 | $14,705,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,661,000 | 0.38% |